Athos Capital Ltd bought a new position in shares of Alere Inc. (NYSE:ALR) during the second quarter, Holdings Channel reports. The institutional investor bought 60,000 shares of the medical research company’s stock, valued at approximately $3,011,000. Alere makes up approximately 1.7% of Athos Capital Ltd’s holdings, making the stock its 17th largest position.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Schwab Charles Investment Management Inc. increased its position in Alere by 9.3% in the second quarter. Schwab Charles Investment Management Inc. now owns 444,308 shares of the medical research company’s stock worth $22,300,000 after buying an additional 37,629 shares in the last quarter. Kassirer Asset Management Corp bought a new position in Alere during the second quarter worth $1,004,000. Longfellow Investment Management Co. LLC increased its position in Alere by 72.1% in the second quarter. Longfellow Investment Management Co. LLC now owns 346,000 shares of the medical research company’s stock worth $17,366,000 after buying an additional 145,000 shares in the last quarter. Aperio Group LLC increased its position in Alere by 9.3% in the second quarter. Aperio Group LLC now owns 12,992 shares of the medical research company’s stock worth $652,000 after buying an additional 1,101 shares in the last quarter. Finally, State of Alaska Department of Revenue increased its position in Alere by 6.6% in the second quarter. State of Alaska Department of Revenue now owns 9,760 shares of the medical research company’s stock worth $489,000 after buying an additional 606 shares in the last quarter. 90.06% of the stock is owned by hedge funds and other institutional investors.

Alere Inc. (NYSE ALR) opened at 49.79 on Thursday. The company’s market capitalization is $4.36 billion. The stock’s 50 day moving average is $50.22 and its 200-day moving average is $45.26. Alere Inc. has a 52-week low of $34.41 and a 52-week high of $50.63.

TRADEMARK VIOLATION NOTICE: This piece of content was originally published by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/athos-capital-ltd-buys-new-stake-in-alere-inc-nysealr/1470317.html.

A number of research firms have recently weighed in on ALR. BidaskClub downgraded shares of Alere from a “hold” rating to a “sell” rating in a research report on Wednesday. Zacks Investment Research raised shares of Alere from a “sell” rating to a “hold” rating in a research report on Tuesday, June 27th. Canaccord Genuity downgraded shares of Alere from a “buy” rating to a “hold” rating and set a $51.00 target price for the company. in a research report on Tuesday, June 6th. Jefferies Group LLC reissued a “hold” rating and set a $51.00 target price on shares of Alere in a research report on Thursday, June 1st. Finally, BTIG Research reissued a “hold” rating on shares of Alere in a research report on Wednesday, May 24th. One research analyst has rated the stock with a sell rating and six have assigned a hold rating to the company’s stock. Alere has an average rating of “Hold” and an average target price of $48.00.

Alere Company Profile

Alere Inc is a provider of health information through diagnostic tests. The Company’s segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus.

Want to see what other hedge funds are holding ALR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alere Inc. (NYSE:ALR).

Institutional Ownership by Quarter for Alere (NYSE:ALR)

Receive News & Ratings for Alere Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alere Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.